Abstract
Cis prolyl peptide bonds are conserved structural elements in numerous protein families, although their formation is energetically unfavorable, intrinsically slow and often rate-limiting for folding. Here we investigate the reasons underlying the conservation of the cis proline that is diagnostic for the fold of thioredoxin-like thiol-disulfide oxidoreductases. We show that replacement of the conserved cis proline in thioredoxin by alanine can accelerate spontaneous folding to the native, thermodynamically most stable state by more than four orders of magnitude. However, the resulting trans alanine bond leads to small structural rearrangements around the active site that impair the function of thioredoxin as catalyst of electron transfer reactions by more than 100-fold. Our data provide evidence for the absence of a strong evolutionary pressure to achieve intrinsically fast folding rates, which is most likely a consequence of proline isomerases and molecular chaperones that guarantee high in vivo folding rates and yields.
The cis/trans isomerization of prolyl peptide bonds is an intrinsically slow reaction and generally rate-limiting for in vitro refolding of proteins harboring cis prolyl peptide bonds in their native, three-dimensional structure1. About 6% of the X-Pro peptide bonds in high-resolution X-ray structures of proteins adopt the cis conformation, while cis is only identified in about 0.04% of the non-prolyl peptide bonds2. The relatively high frequency of cis X-Pro peptide bonds in protein structures can be explained by the fact that the cis conformer is only about 5 kJ mol−1 less stable than the trans conformer3. In chemically denatured proteins, this low energy difference is also responsible for the accumulation of 5–30% nonnative cis X-Pro peptide bonds at prolines that are otherwise in trans in the native state (N)3. This leads to the artificial accumulation of slow-folding molecules in in vitro protein folding studies in which refolding is initiated by rapid dilution from high to low denaturant concentration, and can significantly complicate the analysis of protein folding kinetics4.
The goal of the present study was to establish a model system for studying the coupling between the trans-to-cis isomerization of a X-Pro peptide bond and conformational folding independently of in vitro folding artifacts caused by multiple, nonnative prolyl peptide bonds accumulating in the unfolded state (U). In addition, we intended to find the reasons underlying the strict conservation of cis prolyl peptide bonds in certain protein folds. As a model system, we selected Escherichia coli thioredoxin (Trx), the prototype of a disulfide oxidoreductase family that is found in all three domains of life5,6. E. coli Trx (108 residues) acts as a cytoplasmic reductant of multiple substrates, including ribonucleotide reductase7, methionine sulfoxide reductase8, PAPS reductase9, peroxidoredoxins10,11, and the transmembrane reductase DsbD12, and receives reducing equivalents from NADPH via thioredoxin reductase. The conserved Trx fold (Fig. 1a) consists of a four-stranded β-sheet flanked by three α-helices13,14, a catalytic cysteine pair (Cys32 and Cys35) at the N-terminal end of the second α-helix, and an invariant cis prolyl peptide bond (Ile75-Pro76) that is buried and located next to the active-site cysteine pair (residue numbering of E. coli Trx)15.
Wild type (WT) Trx shows a complex in vitro folding mechanism with multiple kinetic intermediates16 that is dominated by a rate-limiting trans-to-cis isomerization of the Ile75-Pro76 peptide bond17. The folding kinetics are additionally complicated by the four trans prolines (residues 34, 40, 64, and 68) of Trx (Fig. 1a) that partially accumulate a non-native cis conformation in U. The results indicated that denatured Trx is a mixture of three kinetically distinct, unfolded species (UVR, UR, and UM) that differ in the conformation of the five prolines and collapse to structured intermediates (IVR, IR, and IM) within the dead time (3 ms) of stopped-flow mixing (Fig. 2). The minor species UVR possesses all five prolines in the native conformation, collapses to IVR and very rapidly reaches N. The two major unfolded species UR and UM have Pro76 in the nonnative trans conformation. One of these species likely represents molecules with all five prolines in trans, while the other corresponds to unfolded molecules with Pro76 in trans and one of the other four prolines in the nonnative cis conformation. Both intermediates IM and IR react to the intermediate IS with all prolines in the trans conformation, and the slow reaction of IS to N (half-live: 280 s) involves the trans-to-cis isomerization of Pro76 as the common rate-limiting folding step for the majority of Trx molecules (Fig. 2). To study the coupling between folding and the trans-to-cis isomerization of a single X-Pro peptide bond in a best-defined experimental set-up, we used the single-proline variant Trx1P, in which the four trans prolines of Trx were replaced by alanines. Trx1P shows WT-like reductase reactivity, and its X-ray structure is virtually identical to that of Trx WT, with the single Pro76 in cis18. We show that 95% of the Trx1P molecules accumulate a highly stable intermediate (Itrans) with Pro76 in trans, which reaches N only extremely slowly. Replacement of Pro76 by alanine accelerated folding of the resulting, proline-free variant Trx0P 66’000-fold. The X-ray structure of Trx0P revealed a trans Ala76 bond and only small structural rearrangements relative to Trx1P, but the activity of Trx0P as electron transfer catalyst dropped about 100-fold relative to Trx WT. Our results show that optimal interaction with in vivo electron donors and acceptor substrates dominated over fast folding rates in the molecular evolution of thioredoxins.
Results
The X-ray structure of Trx0P shows how the Trx fold can adapt to a trans 75-76 peptide bond
To test the ability of the Trx fold of tolerating a trans peptide bond at the position of the conserved Pro76, the proline-free variant Trx0P was produced as soluble protein in E. coli, purified with high yields and crystallized. The X-ray structure of the oxidized form of Trx0P was solved at 1.65 Å resolution by molecular replacement using the structure of oxidized Trx1P (Trx1Pox) (PDB ID 4HU7)18 as search model. Data collection and refinement parameters are summarized in Supplementary Table 1. Overall, the structure of Trx0Pox is highly similar to that of Trx WTox and Trx1Pox (RMSDs of 0.724–0.915 Supplementary Table 2, Supplementary Fig. 1a, Supplementary Fig. 2) and shows the classical Trx fold with all regular secondary structure elements preserved (Fig. 1b). However, in contrast to Trx WT and Trx1P, the 75-76 peptide bond in Trx0P (Ile-Ala) adopts the trans conformation.
Notably, the 180° rotation around the 75–76 peptide bond in Trx0P relative to Trx1P is compensated by a structural rearrangement of the hexapeptide segment 70–75 N-terminal to the trans Ala76, which is part of the irregular secondary structure preceding β-strand 4. The position of β-strand 4 (residues 77–82) directly C-terminal to residue 76 is identical in the structures of Trx1P and Trx0P and an essential element of the central β-sheet of the thioredoxin fold, providing a plausible explanation for the fact that the polypeptide main chain around residue 76 only changed its conformation in the segment N-terminal to residue 76 in the Trx0P structure (Fig. 1b–e). The trans conformation of the 75–76 bond in Trx0P also translates into a slight, but significant conformational change in the polypeptide segment 30–35 harboring the active-site disulfide (Cys32 and Cys35), and structural rearrangements in the segments 39–41 and 92–95 (Fig. 1d). The overall r.m.s. deviation in the main-chain atoms (Cα) between Trx1P and Trx0P is 0.914 Å (Fig. 1c,d), while it reaches values above 2.5 Å for R73, G74, and I75 next to the Pro76Ala replacement. The movement of the loop segment 70–75 likely causes a loss of van der Waals contacts with the active site disulfide, as Ile75 is no longer packed against the segment harboring the active site as a consequence of its 180° side chain flip (Fig. 1d and Supplementary Fig. 1a). An analogous variant of the periplasmic, thioredoxin-like oxidoreductase DsbA (Supplementary Fig. 1b) in which the conserved cis Pro151 was replaced by Ala, also resulted in formation of a trans peptide bond (Val150-Ala151)19. In contrast to Trx0P, however, the structural rearrangements accommodating the new trans peptide bond were even smaller and limited to the residues 149–152 (Supplementary Fig. 1b). Together, the structures of Trx0P and DsbA (Pro151Ala) reveal a surprisingly high tolerance of the Trx fold for a trans peptide bond at the position of its conserved cis proline.
The trans peptide bond 75-76 in Trx0P leads to a dramatic loss in enzymatic activity
To characterize the functional consequences of the trans 75–76 peptide bond in Trx0P, we first compared the thermodynamic stabilities of the oxidized and reduced forms of Trx0P, Trx1P, and Trx WT at pH 7.0, 25 °C and a ionic strength (I) of 20 mM with guanidinium chloride (GdmCl)-induced unfolding and refolding transitions. All transitions proved to be fully reversible and were evaluated according to the two-state model of protein folding20 (Fig. 3a, Table 1). While the oxidized form of Trx WT was 12.0 ± 0.3 kJ mol−1 more stable than the reduced form, with a shift in the transition midpoint by 0.74 M GdmCl to higher GdmCl concentration, both redox forms of Trx1P showed essentially the same stability and transition midpoints (Fig. 3a, Table 1). Notably, the situation was reversed for Trx0P relative to Trx WT, where the reduced form was 7.6 ± 0.4 kJ mol−1 more stable than the oxidized form, showing an increase in the transition midpoint by 0.79 M GdmCl relative to Trx0Pox. The more stable oxidized form is a hallmark of Trx WT, which shows a highly reducing redox potential of −270 mV21,22. The formal thermodynamic linkage of the stability difference between the oxidized and reduced form of thioredoxin-like disulfide oxidoreductases with their disulfide exchange equilibrium constants with thiol/disulfide substrates23,24,25,26 predicted that Trx1P is more oxidizing than Trx WT, and that Trx0P is more oxidizing than Trx1P. This was indeed confirmed when we measured the redox potentials of Trx0P and Trx1P under identical conditions (pH 7.0, 25 °C, I = 20 mM) by equilibrium titration with mixtures of oxidized and reduced glutathione (GSSG and GSH, respectively). We determined the redox potentials of Trx0P and Trx1P to be −229 mV and −240 mV, respectively (Fig. 3b).
Table 1. Thermodynamic and kinetic parameters of folding of thioredoxin variants 25 °C and pH 7.0.
Thermodynamic parameters of
GdmCl-dependent unfolding/refolding equilibria of the thioredoxin
variants, and folding rates Trx WTox and
Trx1Pox involving the trans-to-cis
isomerization of Pro76* | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Trx variant | meq (kJ mol−1 M−1) | D1/2 (M GdmCl) | ΔD1/2a (M GdmCl) | ΔΔG0ox/red at the mean D1/2b (kJ mol−1) | kItrans→Ncis (s−1)c | |||||||
Trx WTox | 15.9 ± 0.34 | 2.24 | 0.74 | 12.0 ± 0.3 | 3.11 ± 0.20 · 10−3 | |||||||
Trx WTred | 16.5 ± 0.50 | 1.50 | n.d.g | |||||||||
Trx0Pox | 9.53 ± 0.43 | 1.97 | −0.79 | −7.6 ± 0.4 | n.a.h | |||||||
Trx0Pred | 9.82 ± 0.64 | 2.76 | n.a.h | |||||||||
Trx1Pox | 13.3 ± 0.29 | 2.85 | 0.06 | 0.8 ± 0.1 | 1.16 ± 0.15 · 10−4 | |||||||
Trx1Pred | 11.8 ± 0.32 | 2.79 | n.d.g | |||||||||
Kinetic parameters of unfolding and refolding that are independent of proline cis/trans isomerization ** | ||||||||||||
Trx variant | kFH2O (s−1) | kUH2O (s−1) | mFd (M−1) | m U d (M) −1 | ΔG0kin (kJ mol−1) | mkin (kJ mol−1 M−1) | ||||||
Trx0Pox | 7.70 ± 0.76 | 7.00 ± 1.3 ∙ 10−3 | −1.69 ± 0.10 | 2.17 ± 0.06 | −17.4 ± 2.0 | 9.56 ± 0.40e | ||||||
Trx1Pox | n.d.g | 9.56 ± 0.12 ∙ 10−7 | n.d.g | 3.55 ± 0.05 | n.d.g | n.d.g | ||||||
Trx1Pox Itrans | 7.52 ± 0.77f | 1.14 ± 0.62 ∙ 10−4 f | n.a.h | n.a.h | −27.5 ± 2.4f | 12.7 ± 1.89f |
aDifference between the transition midpoints of both redox forms, defined as D1/2 (ox)−D1/2 (red).
bTo avoid errors due to extrapolation to zero denaturant, the differences between the free energies of folding of the oxidized and reduced forms was calculated at the GdmCl concentrations corresponding to the mean value of the respective transition midpoints (D1/2 mean). D1/2 mean values were 1.87, 2.37 and 2.82 M GdmCl for Trx WT, Trx0P and Trx1P, respectively. The ΔΔG0ox/red values are defined such that positive values mean that the oxidized form is more stable than the reduced form.
cRate constant of the rate-limiting step in the folding of the majority of molecules (94% in the case of Trx WTox and 95% in the case of Trx1Pox) involving the trans-to-cis isomerization of the Ile75-Pro76 peptide bond, determined in the presence of 0.2 M GdmCl by interrupted refolding experiments (cf. Fig. 4a and Supplementary Fig. 3).
dKinetic m values, corresponding to the linear dependence of ln kF and ln kU on GdmCl concentration.
eEquilibrium m value predicted from kinetic data with the equation mkin = (mU–mF)·RT.
fThe GdmCl dependence of the observed rate of folding/unfolding of Itrans (Fig. 4c) was evaluated according to a mechanism with a high-energy on-pathway intermediate (U↔I↔N) with kF = kUI and kU = kNI(kIU/kIN)33): mkin = (Σ|mi|) · RT, with mUI = −0.58 M−1, mIN = −2.22 M−1, mNI = 2.33 M−1 (mIU was fixed to zero); kUI = 7.52 s−1, kIN = 1.44 · 105 s−1, and kNI = 1.64 · 10−3 s−1 (kIU was fixed to 104 s−1). The deduced transition midpoint of Itrans is 2.17 M GdmCl.
gnot determined.
hnot applicable.
**Indicated errors correspond to errors from the fits decribed in the legends to Fig. 4a,c.
Next, we compared the activities of Trx WT, Trx1P and Trx0P as substrates of thioredoxin reductase (TrxR) (Supplementary Table 3, Fig. 3c). All three Trx variants were reduced with very similar kcat values (~10 s−1), but Trx0P showed a 6-fold and 8-fold increased KM value compared to Trx WT and Trx1P, respectively. The small structural changes linked to the trans 75–76 bond thus made Trx0P a significantly worse substrate of TrxR. A similar result had been obtained when the cis Pro76 in Trx WT was replaced by Ala17. The results indicate that TrxR recognizes the WT-like tertiary structure of Trx with very high specificity. Trx0P also showed a dramatically reduced activity as catalyst of the reduction of insulin disulfides by dithiothreitol (DTT)27, which was decreased 17- and 55-fold relative to Trx WT and Trx1P, respectively (Fig. 2d, Supplementary Table 3, Supplementary Fig. 3a). This was clearly due to the slow reduction of insulin disulfides by reduced Trx0P, and not caused by slower regeneration of reduced Trx0P by DTT, as DTT reduced Trx0P even faster than Trx WT (Supplementary Table 3). The diminished reductase activity of Trx0P also agrees qualitatively with the more oxidizing redox potential of Trx0P relative to Trx WT and Trx1P. On the whole, despite the comparably small structural differences to Trx WT and Trx1P, the price to be paid for the trans 75–76 bond in Trx0P is strikingly high: the lower activities of Trx0P as acceptor of electrons from TrxR and, in particular, as donor of electrons to protein substrates predict that the in vivo activity of Trx0P would be about 100-fold lower compared to that of Trx WT.
Trx0P folds four orders of magnitude faster than Trx1P
We next measured the folding kinetics for the oxidized forms of Trx WT, Trx1P and Trx0P at 25 °C and pH 7.0. For Trx0P unfolding and refolding was recorded by stopped-flow tryptophan fluorescence between 0.2 and 4 M GdmCl. Under all conditions, mono-exponential fluorescence traces without burst phases were obtained. Notably, a plot of the apparent rate constants of unfolding/refolding of Trx0P against GdmCl concentration (Fig. 4c) revealed a dynamic two-state folding equilibrium with a free energy of folding (ΔG0) of −17.4 ± 2.0 kJ mol−1 and a cooperativity (meq) of 9.56 ± 0.40 kJ mol−1 M−1. The values are identical within experimental error to the corresponding parameters obtained with equilibrium unfolding of oxidized Trx0P (−18.8 ± 0.9 kJ mol−1 and 9.53 ± 0.43 kJ mol−1 M−1, respectively) (Fig. 3a, top panel; Fig. 4c, Table 1). The recorded fluorescence change during refolding thus directly reported the formation of native molecules, with an extrapolated rate constant of folding (kF) at zero denaturant of 7.70 ± 0.76 s−1, corresponding to half-life of 90 ms. Figure 4a shows the folding kinetics (normalized fluorescence trace) at 0.2 M GdmCl, with kF = 3.5 s−1 and a half-life of 200 ms. The highly complex folding mechanism reported for Trx WT (Fig. 2) thus turned into the simplest possible mechanism through the replacement of all prolines by alanine.
Next, we monitored the kinetics of formation of N for Trx WT and Trx1P. Trx WT shows multiple kinetic phases during refolding in stopped-flow fluorescence experiments that however did not allow the quantification of native molecules28. We therefore applied interrupted refolding experiments that detect the concentration of N at any refolding time and the fractions of fast and slow refolding molecules28,29,30 (see Supplementary Fig. 3 for details). Trx WT and Trx1P were unfolded for at least 1.5 h at 25 °C and pH 7.0 in 4 M GdmCl to attain the cis/trans equilibrium of all prolyl peptide bonds before refolding was initiated by 1:20 dilution to 0.2 M GdmCl. The refolding was stopped after different times by addition of GdmCl to concentrations (2.88 M GdmCl for Trx WT, 3.45 M for Trx1P) where N unfolded with a half- life of about 30 s and any intermediate unfolded in the dead time of manual mixing. As both Trx WT and Trx1P refolded quantitatively under the chosen conditions, the amplitudes of the slow, monoexponential unfolding reactions could be converted to fraction of N and were plotted against refolding time. Figure 4a and Supplementary Fig. 3 show the kinetics of N formation for Trx WT and Trx1P compared to Trx0P at 0.2 M GdmCl. For Trx WT, the data were fully consistent with the previously proposed folding mechanism15 (Fig. 2) with a minor fraction of 6 ± 3% fast folders and a main fraction (94%) of slow folders. The slow folders accumulated a single, rate-limiting intermediate (IS in Fig. 2) with Pro76 in trans that folded to N with a half-life of 222 ± 14 s, in good agreement with the previously reported half-life of 280 s under slightly different conditions16. Trx1P, for which we had expected a higher fraction of fast folders as it cannot accumulate wrong cis prolines at positions 34, 40, 64, and 68 in U, also only showed a fraction of 5 ± 2% fast folders. This is possibly due to residual structure affecting the cis/trans equilibrium of the Ile75-Pro76 peptide bond in the unfolded state. The major fraction of slow Trx1P folders reacted to N extremely slowly with a half-life of 99.1 ± 12.8 min. Thus, the four trans prolines in Trx WT accelerate the rate-limiting cis-to-trans isomerization of Pro76 27-fold relative to Trx1P. This may result from a significant change in the energy landscape through the replacement of the four trans prolines by trans alanines in Trx1P that even affects the late, rate-limiting folding reaction to the energetically most stable, native state31,32. More importantly, the results show that the single amino acid substitution Pro76Ala converting Trx1P into Trx0P accelerates folding to the thermodynamically most stable state (N) at zero denaturant by a factor of 66’000.
The folding kinetics of Trx1P at pH 7.0 and 25 °C are consistent with a simple folding mechanism in which U represents a mixture of 5% fast folders with Pro76 in cis (Ucis) that fold directly to N, and 95% slow folders with Pro76 in trans (Utrans) that collapse to a stable intermediate, Itrans, with Pro76 still in trans (Fig. 5). We could reproduce the rate-limiting Itrans-to-N reaction by two independent experiments within experimental error: the recovery of the activity of Trx1P as substrate of TrxR proceeded with a half-life of 79.5 ± 0.5 min, and the recovery of the tryptophan fluorescence of N (Fig. 6a) showed a half-life of 78.2 ± 0.5 min (Supplementary Fig. 4).
In addition, we used the strong fluorescence difference between Itrans and N (Fig. 6a) to measure the activation energy of the Itrans-to-N reaction (Fig. 4b), which proved to be 101.0 ± 2.8 kJ mol−1. This compares to activation energies of 67.6 ± 3.2 kJ mol−1 for folding of Trx0P, and 62.4 ± 1.4 kJ mol−1 for the Utrans-to-Itrans reaction (Fig. 4b).
To verify that folding of Itrans to N is indeed accompanied by the trans-to-cis isomerization of Pro76, we performed interrupted unfolding experiments in which Trx1P was rapidly unfolded by 5 M GdmCl (unfolding completed within 1 s) and incubated in 5 M GdmCl for different times (5–120 s) at 25 °C prior to refolding. The kinetics of attainment of the cis/trans equilibrium of the Ile75-Pro76 bond in unfolded Trx1P were measured via the increase in the fraction of slow folders with increasing incubation time (Supplementary Fig. 5) and yielded an apparent rate constant (kobs) of 1.80 ± 0.35 · 10−2 s−1, consistent with reported rates of cis-to-trans isomerization of prolyl peptide bonds in unstructured peptides3. Combination with the known fractions of fast and slow folders yielded half-lifes of 40 ± 7.7 s and 768 ± 382 s for the cis-to-trans and trans-to-cis isomerization of the Ile75-Pro76 peptide bond in unfolded Trx1P, respectively (Supplementary Fig. 5, Fig. 5).
The intermediate Itrans has a highly stable tertiary structure
The rapid formation of Itrans during Trx1P refolding within the dead time of manual mixing, its high population (95% of the molecules) and in particular its extremely slow reaction to N offered the unique possibility to characterize the folding, stability and function of Itrans in detail. First, we recorded the GdmCl dependence of its unfolding and refolding kinetics by stopped-flow fluorescence (Fig. 4c). The fluorescence traces monitoring the formation of Itrans from unfolded Trx1P could be fitted mono-exponentially with an additional term correcting for the very slow formation of N from Itrans and showed no burst phase. Assuming that fluorescence changes resulting from the small fraction of 5% fast folding molecules were negligible, we assigned the first-order rate constants (kobs) deduced from the fast, main fluorescence change to formation of Itrans. For recording the unfolding kinetics of Itrans, it was first populated to >90% by rapid dilution of Trx1P from 4.0 to 0.2 M GdmCl (<5 min refolding time), and then unfolded again by increasing the GdmCl concentration. As native Trx1P unfolded by more than one order of magnitude slower than Itrans in the range of 2–4 M GdmCl (Fig. 4c) and was populated to less than 10% under these conditions, its contribution to the fast fluorescence change during unfolding of Itrans was minimal, so that all unfolded traces could be fitted mono-exponentially. Figure 4c shows the combined data on the GdmCl dependence of the apparent rate constant (kobs) of folding/unfolding of Itrans, revealing a clear curvature of the folding branch of Itrans. Evaluation according to a mechanism with a high-energy on-pathway folding intermediate33 yielded folding and unfolding rates of 7.52 ± 0.77 s−1 and 1.14 ± 0.62 · 10−4 s−1 at zero denaturant concentration, respectively and a free energy of folding (ΔG0) of −27.5 ± 2.4 kJ mol−1. In addition, the cooperativity of Itrans folding (mkin) of 12.7 ± 1.89 kJ mol−1 M−1 was identical within experimental error to the meq value of 13.3 ± 0.29 for Trx1P measured by equilibrium unfolding (Table 1), demonstrating complete tertiary structure formation in Itrans. Together, Itrans proved to be even 8.7 kJ mol−1 more stable than Trx0P, and only 10.4 kJ mol−1 less stable than N (Table 1, Fig. 7). The tertiary structure of Itrans is likely very similar to that of native Trx0P, which also has the 75–76 peptide bond in trans. Comparison of the extrapolated rate constants of unfolding and refolding (Table 1) shows that the higher stability of Trx0P compared to Itrans is exclusively based on its 120-fold lower rate of spontaneous unfolding, as the proline-independent folding rates are essentially identical for Itrans and Trx0P (Fig. 4c, Table 1). We obtained further, independent evidence for a Trx0P-like tertiary structure of Itrans. First, the tryptophan fluorescence spectrum of Itrans is more similar to that of Trx0P than to the spectrum of native Trx1P, which shows more than 2-fold lower fluorescence intensity than Trx0P (Fig. 6a). Second, the active-site disulfide bond in Itrans showed even a slightly higher reactivity with the reductant dithiothreitol (DTT) than that of native Trx1P and Trx0P, but a more than 200-fold higher reactivity with DTT than the disulfide bond in unfolded, oxidized Trx1P (Fig. 6b, Supplementary Table 3). Third, like Trx0P, Itrans was only weakly recognized as substrate by TrxR (Fig. 6c). Even though the catalytic parameters of Itrans could not be accurately determined due to aggregation at high concentrations during refolding, its KM is similar to that of Trx0P (above 15 μM) and clearly increased relative to the KM values of native Trx1P and Trx WT (Supplementary Table 3). Fourth, we performed fast analytical gel filtration runs showing that the apparent hydrodynamic volume of Itrans was indistinguishable from that of Trx1P and Trx0P within experimental error (Fig. 6d, inset). Together with the notion that folding becomes slower with increasing stability of structured intermediates29, the results suggested that the stable tertiary structure of Itrans is responsible for its very slow reaction to N.
To test whether Itrans can fold directly to N or first needs to unfold before the trans-to-cis isomerization of Pro76 and folding to N can take place, we measured the dependence of the kinetics of folding of Itrans to N on denaturant concentration. Supplementary Fig. 6 shows that N formed independently of GdmCl concentration between 0.2 and 1.0 M, demonstrating that unfolding of Itrans is not required for formation of N. In addition, we recorded refolding kinetics of Trx1P in the presence of a 1.67-fold molar excess of the ribosome-associated proline isomerase trigger factor (TF) from E. coli. TF is a likely catalyst of cis/trans isomerization of prolines during folding of thioredoxin in vivo, as it encapsulates nascent polypeptide chains leaving the ribosomal exit tunnel in a cavity that is large enough to accommodate the 12 kDa protein thioredoxin34,35. However, no acceleration of formation of native Trx1P by TF was observed, even at high concentrations of Trx1P (90 μM) and TF (150 μM) (Fig. 6d). This indicated that the trans Pro76 gets rapidly buried and inaccessible for TF upon the collapse of the polypeptide to Itrans and confirmed that N can be formed from Itrans directly. The inability of TF to catalyze folding of thioredoxin in vitro does however not question a catalytic function of TF in vivo, because ribosome-associated TF should be able to access prolines in disordered, nascent polypeptide chains that remain folding-incompetent prior to completion of protein synthesis.
Discussion
Improved biological function is the critical driving force underlying molecular evolution of proteins36,37. Molecular evolution of the cytoplasmic reductase thioredoxin is a particularly interesting case because Trx not only needs to interact with its electron donor TrxR with very high efficiency (kcat/KM > 106 M−1 s−1, Supplementary Table 4), but also must donate electrons specifically to numerous substrates in vivo. These multiple functions define very stringent structural prerequisites for a functional Trx fold and, in particular, for the specific conformation and local environment of its active-site cysteine pair. In accordance with this notion, we showed that a single replacement of a buried amino acid (Pro76Ala) in the fully functional Trx variant Trx1P (yielding Trx0P) almost completely abolished the function of the protein as electron transfer catalyst. Although the re-orientation of the 75–76 bond from the cis to the trans conformation in Trx0P could be compensated by minor structural rearrangements and did not affect the overall protein fold, the small structural changes in the segment harboring the active-site disulfide were sufficient for an almost complete loss of function as TrxR-dependent reductase (Fig. 3, Supplementary Table 3). Inversely, the results indicate that the appearance of the cis Pro76 may have been a critical step in the evolution of Trx, in agreement with the finding that the diagnostic cis proline had already been present in the oldest bacterial thioredoxins38. But how could the cis proline evolve when it obviously affected the folding rate of Trx so dramatically? Our data on the rates of formation of N in the proline-independent folding of Trx0P and Itrans, show that both proteins form N very rapidly with practically identical rates of ~8 s−1 (Fig. 4c, Table 1). Generation of a cis proline in the Trx fold should thus have slowed folding by at least two orders of magnitude. This may have been compensated by a native-like tertiary structure of Itrans, proline isomerases as folding catalysts and molecular chaperones that increase the folding yield by preventing aggregation of slow folders. In addition, the cost of incorporation of a cis proline into a tertiary structure is formally comparably low (about 5 kJ mol−1), as the trans conformer of a prolyl peptide bond is energetically almost as unfavorable as the cis conformer39.
Figure 7 summarizes our results on the thermodynamics of Trx1P and Trx0P folding. The fact that Trx0P is less stable than Trx1P Itrans suggests a significant stabilization of the Trx fold by Pro76 relative to Ala76, even if Pro76 is in the nonnative trans-conformation. The comparably high free energy of folding of Trx1P Itrans also explains the slow formation of N from Itrans.
The folding mechanism of Trx1P proved to be strongly simplified relative to that of Trx WT16 because the accumulation of nonnative cis prolines in U at the four trans prolines of Trx WT was eliminated. A further simplification was observed upon removal of the last proline in Trx0P, which became a perfect two-state folder. Our results are reminiscent of the elimination of one of the two cis prolines in ribonuclease T1, which also dramatically simplified RNaseT1 folding40. In addition, the 27-fold faster reaction of Itrans to N in Trx WT compared to Trx1P suggests that the four trans prolines in Trx WT destabilize Itrans in Trx WT relative to Itrans in Trx1P. The extremely slow Itrans to N reaction in Trx1P at the level of the intact tertiary structure underlines the strong coupling of folding with proline cis/trans isomerization4.
We showed that the replacement Pro76Ala in Trx1P accelerated folding of the vast majority (95%) of the molecules by a factor of 66’000. This is, to our knowledge, the largest acceleration of protein folding by a single amino acid replacement reported so far. The high acceleration factor is also a consequence of the extremely slow Itrans-to-N reaction in Trx1P folding (t1/2 = 99 min). Indeed there are only very few examples for comparably slow folding reactions in small, one-domain proteins28,41. The very high activation energy of Trx1P folding might even provide the basis for designing a Trx variant that folds under kinetic control and stops folding at the level of Itrans. Folding of Trx1P at 4 °C already proved to be close to kinetic control and reached N only with a half-life of 8 hours (Fig. 4b). Thus, even a slight, further stabilization of Itrans by additional amino acid replacements might suffice to achieve complete kinetic control of folding at 4 °C. Such thioredoxin variants could e.g. be used for technical applications where reductase activity is switched on by a temperature jump.
Methods
Protein production and purification
Trx WT and Trx1P were produced and purified as described previously42. The plasmid for expression of Trx0P was constructed with the QuikChange Site-directed Mutagenesis Kit (Agilent Technologies) using the expression plasmid for Trx1P2 as template. Production of Trx0P in E. coli BL21(DE3) and enrichment with anion exchange chromatography on DE52 cellulose (Whatman) and gel filtration on Superdex 75 (GE Healthcare) under non-reducing conditions was performed exactly as described for Trx WT and Trx1P18. After the gel filtration step, the remaining impurities in the combined fractions containing Trx0P were removed by hydrophobic chromatography on Phenyl Sepharose 6 Fast Flow (GE Healthcare) in 20 mM MOPS-NaOH pH 7.0, using a gradient from 1.5 to zero M ammonium sulfate (20 column volumes). Fractions containing pure Trx0P were combined, dialyzed against 5 mM MOPS-NaOH pH 7.0, and stored at −20 °C. The final yield of pure Trx0P was 11 mg per liter of bacterial culture. Ellman’s assay43 showed that the active-site disulfide bond in Trx0P was formed quantitatively after purification in the absence of reductant, and the correct mass of the protein was verified by ESI mass spectrometry (calculated: 11543.2 Da, found: 11543.3 Da). The concentrations of Trx WT, Trx1P and Trx0P were determined via their specific absorbance at 280 nm (14430 M−1 cm−1 for native, oxidized proteins and 14060 M−1 cm−1 for unfolded, oxidized proteins44).
E. coli thioredoxin reductase was purified as described previously,45 and its concentration was determined via its the specific absorbance at 280 nm (49000 M−1cm−1 for the monomeric holo-enzyme).
The genetic sequence encoding E. coli trigger factor with N-terminal hexahistidine tag was cloned into pET11a via NdeI and BamHI and expressed in E. coli BL21DE3 at 20 °C for 12 h after induction with 0.5 mM IPTG. After cell lysis in 50 mM potassium phosphate pH 8.0, 300 mM NaCl, 2 mM β-mercaptoethanol, 20 mM imidazole, the protein was purified via Ni-NTA affinity chromatography in the same buffer (elution with 40 mM imidazole-HCl), followed by anion exchange chromatography on Resource Q (GE Healthcare) (10 mM potassium phosphate pH 7.5, elution with an NaCl gradient at ~180 mM NaCl) and a final gel filtration step on Superdex 200 (GE Healthcare) in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA. The concentration of trigger factor (yield: 12 mg per liter of bacterial culture) was determined via its specific absorbance at 280 nm (17420 M−1 cm−1), and its identity was confirmed by ESI mass spectrometry (expected mass: 49015.5 Da; found: 49016.0 Da).
Crystallization and structure determination of Trx0Pox
Crystals of Trx0Pox were grown via sitting drop vapor diffusion at 4 °C after mixing 175 nl of Trx0Pox solution (15.5 mg/ml in 20 mM MOPS-NaOH, pH 7.0) with 100 nl of precipitant solution (10% (w/v) PEG 1000, 10% (w/v) PEG 8000). Cryoprotection was achieved by shortly dipping the crystal into a solution of mother liquor with 20% ethylene glycol. Data to a resolution of 1.65 Å were collected at beamline X06DA of the Swiss Light Source (SLS, Villigen, Switzerland) at a wavelength of 1.0 Å. A complete dataset was obtained from a single crystal. Diffraction images were indexed and integrated with XDS46 in space group P21 (a = 34.67 Å, b = 48.57 Å, c = 89.94 Å, α = β = 90°, γ = 101.01°), scaled with XSCALE and converted to amplitudes with XDSCONV and programs of the CCP4 suite47.
The three molecules of Trx0P in the asymmetric unit were positioned by molecular replacement with PHASER48, using the crystal structure of Trx1Pox (PDB 4HU7)2 as search model. Refinement was carried out using PHENIX49. After the first round of refinement, clear difference electron density at the mutation site of P76A mandated the replacement of the cis-proline of Trx1P by a trans-alanine. MolProbity50 was used for structure validation; secondary structure elements were assigned using phenix.ksdssp. Diffraction data and refinement parameters are summarized in Supplementary Table 1.
Denaturant-induced unfolding and refolding equilibria of Trx0P, Trx1P, and Trx WT
Unfolding and refolding equilibrium transitions were measured at 25 °C essentially as described previously18 with the only exception that 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA was used as buffer. Protein concentrations were 16.6 μM. Samples with reduced proteins additionally contained 4 mM DTT. Exact GdmCl concentrations were determined via the refractive index of the solutions. Data were evaluated according to the two-state model of protein folding to determine the free energy (ΔG0) and cooperativity (meq) of folding20.
Interrupted refolding of Trx1Pox and Trx WTox
Interrupted refolding experiments (N-tests) were used to monitor formation of native molecules during refolding of Trx WTox or Trx1Pox, as they detect spectroscopically silent folding steps and quantitatively monitor the fraction of N at any time during refolding30. Proteins were first unfolded in 4.0 M GdmCl, 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA at 25 °C for at least 2 h before initiation of refolding by rapid, 20-fold dilution with 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA at 25 °C. The final concentrations in the refolding reactions were 35 μM Trx and 0.2 M GdmCl. Samples were removed after different refolding times and mixed with an equal volume of GdmCl solution in 50 mM MOPS-NaOH pH 7.0, 1.0 mM EDTA. The final GdmCl concentrations during this unfolding step were 2.88 M and 3.45 M for Trx WTox and Trx1Pox, respectively, and chosen such that native proteins unfolded with half-lives of about 30 s and folding intermediates (including Itrans) unfolded within the dead time of manual mixing. Unfolding reactions at 25 °C were monitored via the increase in the far-UV CD signal at 220 nm with a J715 CD spectrometer (Jasco) and unfolding of N was fitted mono-exponentially (cf. Figure S4). The corresponding amplitudes were plotted against refolding time and normalized, yielding the kinetics of formation of N. The y-axis intercept yielded the fraction of fast folders (folding within the dead time of manual mixing). The folding kinetics of the slow folders could be fitted with a single exponential function for both TrxWTox and Trx1Pox, and were interpreted as the rate-limiting Itrans-to-N transition.
Unfolding and refolding kinetics of Trx0Pox and Trx1Pox Itrans
The rates of unfolding and refolding of oxidized Trx0P and Trx1P Itrans were measured as a function of GdmCl concentration at 25 °C and pH 7.0 using a temperature-controlled SX20 stopped flow spectrophotometer (Applied Photophysics). The final protein concentration was 1.0 μM in all reactions. For refolding reactions, i.e., folding to N in the case of Trx0P and folding to Itrans in the case of Trx1Pox, proteins were first unfolded in 3.0 M GdmCl (Trx0Pox) or 3.6 M GdmCl (Trx1Pox) for at least 2 h at 25 °C, pH 7.0 and then refolded by 1:11 dilution with 50 mM MOPS pH 7.0, 1 mM EDTA containing different GdmCl concentrations. Refolding was recorded by the decrease in fluorescence above 320 nm (excitation at 280 nm). In the case of Trx0Pox, refolding rates were fitted according to a single, mono-exponential equation. In the case of Trx1Pox Itrans, a mono-exponential equation with an additional, linear term correcting for the slow fluorescence change caused by the subsequent slow proline-trans-to-cis isomerization was used. Unfolding of Trx0Pox was performed by rapid mixing of the native protein with the 10-fold volume of 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA containing different GdmCl concentrations, so that the final GdmCl concentrations varied between 2.1 and 4.0 M. Kinetics were fitted mono-exponentially. For recording unfolding kinetics of Trx1Pox Itrans, unfolded Trx1Pox (in 4.0 M GdmCl) was refolded by dilution with 20 volumes of 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA, and immediately unfolded again by 1:11 dilution into unfolding buffers resulting in final GdmCl concentrations of 2.3–4.2 M. Kinetic traces could be fitted mono-exponentially. The contribution of native Trx1Pox (5% of the molecules) proved to be negligible. The logarithms of the apparent rate constants of folding and unfolding were plotted against GdmCl concentrations. Data on Trx0P were fitted according to the two state model of protein folding51. For Trx1Pox Itrans, data were fitted according to a model assuming a high-energy on-pathway intermediate (see legend to Table 1 for the deduced kinetic parameters)33.
Fluorescence and CD spectroscopy
Fluorescence emission spectra of oxidized Trx0P, Trx1P, and Trx1P Itrans immediately after start of refolding (rapid dilution from 4.0 M GdmCl to 0.2 M GdmCl) were recorded at 25 °C in 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA containing 0.2 M GdmCl using a temperature-controlled Quantum Master 7 fluorescence spectrometer (PTI). The excitation wavelength was 280 nm in all measurements.
Far-UV and near-UV CD spectra of oxidized Trx WT, Trx0P, and Trx1P were recorded in 5 mM KH2PO4-KOH pH 7.0 at 25 °C using a temperature-controlled J715 CD spectrometer (Jasco). The protein concentrations in far-UV and near-UV CD measurements were 0.2 mg/ml and 0.4 mg/ml, respectively. CD signals were converted to mean residue ellipticity. The far-UV CD spectrum of Trx1P Itrans was recorded immediately after the initiation of refolding of Trx1P at 25 °C in 50 mM MOPS-NaOH, 1 mM EDTA, 0.2 M GdmCl pH 7.0.
Activity of Trx0P, Trx1P, and Trx1P Itrans as a substrate of thioredoxin reductase (TrxR)
The activities of Trx0P, Trx1P and Trx1P Itrans as substrates of TrxR at pH 8.0 and 25 °C were measured as described previously45 at constant TrxR concentrations of 40 nM (monomer), with the exception that 1 mM DTNB (5,5’-dithiobis-(2-nitrobenzoic acid), Ellman’s reagent) and 500 μM NADPH in a final reaction volume of 360 μl were used and all reactions contained 20 mM GdmCl. Samples of Trx1Pox Itrans were obtained immediately after refolding of Trx1Pox in 0.2 M GdmCl, 50 mM MOPS-NaOH pH 7.0, 1 mM EDTA). The reactions were initiated by addition of TrxR and followed by the absorbance increase at 412 nm as a result of the reduction of DTNB by reduced thioredoxin. The initial velocities were plotted against substrate concentrations and evaluated according to Michaelis-Menten kinetics. For calculation of kcat values, a molar extinction coefficient of 28300 M−1cm−1 was used for the two TNB molecules formed per catalytic cycle.
As an alternative to the N-test, the rate of formation of native Trx1Pox from Itrans was monitored by measuring the increase in the activity as substrate of TrxR as a function of refolding time. Refolding of unfolded Trx1Pox was started as described above (10 μM Trx in the refolding reaction containing 0.2 M GdmCl) at 25 °C and pH 7.0. After different refolding times, samples were removed and diluted 1:10 with TrxR reaction buffer (0.1 M Tris-HCl pH 8.0, 0.25 mM EDTA, 0.25 mg/ml BSA, 1 mM DTNB, 0.5 mM NADPH), resulting in final concentrations of 1 μM Trx and 20 mM GdmCl in the TrxR activity assay. The initial reaction velocities were plotted against refolding time and the rate of formation of native Trx1Pox was determined assuming Michaelis-Menten type substrate activity for Itrans and native Trx1P according to equation (1),
where vobs is the observed initial reaction velocity, vmax(N) and vmax(I) are the maximum reaction velocities of native Trx1P and Trx1P Itrans, respectively, c0 is the total concentration of Trx1P, ff is the fraction of fast folding molecules (0.05), k is the rate constant of the Itrans-to-N reaction, and KM(N) and KM(I) are the Michaelis constants of native Trx1P and Trx1P Itrans, respectively. vmax(I) was assumed to be identical to vmax(N) based on the observation that vmax with Trx0P as substrate proved to be identical to vmax(N) of native Trx1P.
Rate of attainment of of the cis/trans equilibrium of Pro76 in unfolded Trx1P
The rate of proline cis-to-trans isomerization in unfolded proteins can be determined by interrupted unfolding experiments30,52. First, native Trx1Pox (100% cis Pro76) was rapidly unfolded at 25 °C and pH 7.0 in 5.0 M GdmCl (unfolding half-life < 1 s). After different incubation times in 5 M GdmCl, refolding was initiated by rapid dilution with 50 mM MOPS-NaOH, 1 mM EDTA pH 7.0 to a final GdmCl concentration of 0.2 M). TrxR substrate activity of Trx1Pox during refolding was recorded as described above and the activity increase as a function of refolding time was fitted mono-exponentially. As a consequence of formation of trans Pro76 in unfolded Trx1Pox, the amplitudes of the slow activity increase of Trx1Pox as TrxR substrate during refolding increased with unfolding time (cf. Figure S5A). The amplitudes were plotted against unfolding time (Supplementary Fig. 5B) and yielded the apparent rate constant (kobs) of attainment of the cis/trans equilibrium of Pro76 in unfolded Trx1Pox.
Kinetics of reduction of Trx WT and variants by DTT
Kinetics of reduction of oxidized Trx0P, Trx1P, or Trx1P Itrans by DTT were recorded at 25 °C in 50 mM MOPS-NaOH, pH 7.0 under pseudo-first-order conditions. Oxidized thioredoxins (2.0 μM) were mixed with 200, 100, 50 or 20 μM DTT in a temperature-controlled Quantum Master 7 fluorescence spectrometer. For each Trx variant, the increase in tryptophan fluorescence at 345 nm (excitation at 280 nm) upon reduction was fitted globally to pseudo-first-order kinetics. The kinetics of reduction of unfolded Trx1P could also be followed by an increase in tryptophan fluorescence, which is most likely caused by quenching of the fluorescence of Trp31 by the Cys32-Cys35 disulfide in the unfolded protein.
Redox equilibria with glutathione
The redox equilibrium between Trx0P or Trx1P and GSH/GSSG (eq. 2) was determined essentially as described previously42, making use of the increase in tryptophan fluorescence upon reduction of Trx and assuming that mixed disulfides between Trx and glutathione are not significantly populated at equilibrium. Trx1Pox or Trx0Pox (2 μM) were mixed with GSSG (10 μM) and variable concentrations of GSH (0.015–33 mM). After incubation under argon atmosphere for 5 h at 25 °C in 100 mM KH2PO4/K2HPO4 pH 7.0, 1 mM EDTA, the fluorescence at 345 nm was recorded (excitation at 295 nm). As the GSH preparation contained small impurities of GSSG, the true GSSG concentration in all samples was determined immediately after each fluorescence measurement via glutathione reductase-catalyzed NADPH oxidation as described previously53. The equilibrium constant (Keq, eq. 2) was determined by fitting the fluorescence data according to equation 3, where F is the measured fluorescence and Fox and Fred are the fluorescence intensities of oxidized and reduced Trx, respectively. Redox potentials were calculated with the Nernst equation (eq. 4), using a value of −240 mV for the standard redox potential of glutathione54.
Thioredoxin-catalyzed reduction of insulin by DTT
The activity of Trx0P and Trx1P as catalysts of the reduction of horse insulin (130 μM) by DTT (1 mM) was measured at 25 °C and pH 7.0 as described previously18, except that a final DTT concentration of 1.0 mM was used. The final concentration of Trx was varied between zero and 20 μM. The aggregation of insulin as a consequence of reduction of insulin disulfides was followed via the increase in optical density (OD) at 600 nm. The time required to reach an OD600 nm value of 0.1 was defined as the time of aggregation onset and plotted against Trx concentration. The time of aggregation onset was 44.1 ± 0.3 min for the uncatalyzed reaction.
Data analysis and statistics
The quantitative evaluation of the data provided in Table 1 and Figs 3,4 and 6 was performed according to the equations/models indicated in the figure legends, using Kaleidagraph (Synergy Software) or Sigmaplot (Systat Software Inc.). Evaluation of the folding kinetics of Itrans according to a high-energy on-pathway intermediate was performed with proFit (QuantumSoft). If not stated otherwise, the given errors result from the fits to the indicated equations/models.
Additional Information
How to cite this article: Roderer, D. J. A. et al. Acceleration of protein folding by four orders of magnitude through a single amino acid substitution. Sci. Rep. 5, 11840; doi: 10.1038/srep11840 (2015).
Supplementary Material
Acknowledgments
We thank Dr. Guido Capitani (Paul Scherrer Institut, Villigen, CH) and Dr. Cristoph Giese (ETH Zürich) for helpful discussions. We are grateful to Flurin Sturzenegger for initial kinetic experiments and Hiang Dreher for technical assistance. We thank the staff at beamline X06DA of SLS for excellent support.
Footnotes
Author Contributions M.R., D.J.A.R. and R.G. designed the experiments. R.G. cloned Trx0P and purified all Trx variants; M.A.S. solved the crystal structure of Trx0P and performed experiments for characterization of Trx0P; D.J.A.R. performed all interrupted refolding and unfolding experiments, as well as most of the kinetic experiments; M.R. performed GdmCl-dependent equilibrium unfolding and refolding transitions and thioredoxin reductase assays. R.G., D.J.A.R. and M.R. analyzed the data. All the authors wrote the manuscript.
References
- Schmid F. X. Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. Annual review of biophysics and biomolecular structure 22, 123–142, 10.1146/annurev.bb.22.060193.001011 (1993). [DOI] [PubMed] [Google Scholar]
- Jabs A., Weiss M. S. & Hilgenfeld R. Non-proline cis peptide bonds in proteins. Journal of molecular biology 286, 291–304, 10.1006/jmbi.1998.2459 (1999). [DOI] [PubMed] [Google Scholar]
- Reimer U. et al. Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J Mol Biol 279, 449–460, 10.1006/jmbi.1998.1770 (1998). [DOI] [PubMed] [Google Scholar]
- Schmidpeter P. A., Koch J. R. & Schmid F. X. Control of protein function by prolyl isomerization. Biochimica et biophysica acta, 10.1016/j.bbagen.2014.12.019 (2014). [DOI] [PubMed] [Google Scholar]
- Susanti D. et al. Thioredoxin targets fundamental processes in a methane-producing archaeon, Methanocaldococcus jannaschii. Proceedings of the National Academy of Sciences of the United States of America 111, 2608–2613, 10.1073/pnas.1324240111 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collet J. F. & Messens J. Structure, function, and mechanism of thioredoxin proteins. Antioxid Redox Signal 13, 1205–1216, 10.1089/ars.2010.3114 (2010). [DOI] [PubMed] [Google Scholar]
- Sengupta R. & Holmgren A. Thioredoxin and glutaredoxin-mediated redox regulation of ribonucleotide reductase. World J Biol Chem 5, 68–74, 10.4331/wjbc.v5.i1.68 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lowther W. T., Brot N., Weissbach H., Honek J. F. & Matthews B. W. Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase. Proceedings of the National Academy of Sciences of the United States of America 97, 6463–6468 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lillig C. H. et al. New thioredoxins and glutaredoxins as electron donors of 3’-phosphoadenylylsulfate reductase. J Biol Chem 274, 7695–7698 (1999). [DOI] [PubMed] [Google Scholar]
- Biteau B., Labarre J. & Toledano M. B. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425, 980–984, 10.1038/nature02075 (2003). [DOI] [PubMed] [Google Scholar]
- Arner E. S. & Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267, 6102–6109 (2000). [DOI] [PubMed] [Google Scholar]
- Stirnimann C. U., Grutter M. G., Glockshuber R. & Capitani G. nDsbD: a redox interaction hub in the Escherichia coli periplasm. Cell Mol Life Sci 63, 1642–1648, 10.1007/s00018-006-6055-1 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Katti S. K., LeMaster D. M. & Eklund H. Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution. J Mol Biol 212, 167–184, 10.1016/0022-2836(90)90313-B (1990). [DOI] [PubMed] [Google Scholar]
- Dyson H. J., Gippert G. P., Case D. A., Holmgren A. & Wright P. E. Three-dimensional solution structure of the reduced form of Escherichia coli thioredoxin determined by nuclear magnetic resonance spectroscopy. Biochemistry 29, 4129–4136 (1990). [DOI] [PubMed] [Google Scholar]
- Cheng Z., Zhang J., Ballou D. P. & Williams C. H. Jr. Reactivity of thioredoxin as a protein thiol-disulfide oxidoreductase. Chem Rev 111, 5768–5783, 10.1021/cr100006x (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Georgescu R. E., Li J. H., Goldberg M. E., Tasayco M. L. & Chaffotte A. F. Proline isomerization-independent accumulation of an early intermediate and heterogeneity of the folding pathways of a mixed alpha/beta protein, Escherichia coli thioredoxin. Biochemistry 37, 10286–10297, 10.1021/bi9805083 (1998). [DOI] [PubMed] [Google Scholar]
- Kelley R. F. & Richards F. M. Replacement of proline-76 with alanine eliminates the slowest kinetic phase in thioredoxin folding. Biochemistry 26, 6765–6774 (1987). [DOI] [PubMed] [Google Scholar]
- Rubini M., Scharer M. A., Capitani G. & Glockshuber R. (4R)- and (4S)-fluoroproline in the conserved cis-prolyl peptide bond of the thioredoxin fold: tertiary structure context dictates ring puckering. Chembiochem 14, 1053–1057, 10.1002/cbic.201300178 (2013). [DOI] [PubMed] [Google Scholar]
- Charbonnier J. B., Belin P., Moutiez M., Stura E. A. & Quemeneur E. On the role of the cis-proline residue in the active site of DsbA. Protein Sci 8, 96–105, 10.1110/ps.8.1.96 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scholtz J. M., Grimsley G. R. & Pace C. N. Solvent denaturation of proteins and interpretations of the m value. Methods Enzymol 466, 549–565, 10.1016/S0076-6879(09)66023-7 (2009). [DOI] [PubMed] [Google Scholar]
- Lin T. Y. & Kim P. S. Urea dependence of thiol-disulfide equilibria in thioredoxin: confirmation of the linkage relationship and a sensitive assay for structure. Biochemistry 28, 5282–5287 (1989). [DOI] [PubMed] [Google Scholar]
- Krause G., Lundstrom J., Barea J. L., Pueyo de la Cuesta C. & Holmgren A. Mimicking the active site of protein disulfide-isomerase by substitution of proline 34 in Escherichia coli thioredoxin. J Biol Chem 266, 9494–9500 (1991). [PubMed] [Google Scholar]
- Lee S., Kim S. M. & Lee R. T. Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid Redox Signal 18, 1165–1207, 10.1089/ars.2011.4322 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grauschopf U. et al. Why is DsbA such an oxidizing disulfide catalyst? Cell 83, 947–955 (1995). [DOI] [PubMed] [Google Scholar]
- Zapun A., Bardwell J. C. & Creighton T. E. The reactive and destabilizing disulfide bond of DsbA, a protein required for protein disulfide bond formation in vivo. Biochemistry 32, 5083–5092 (1993). [DOI] [PubMed] [Google Scholar]
- Nelson J. W. & Creighton T. E. Reactivity and ionization of the active site cysteine residues of DsbA, a protein required for disulfide bond formation in vivo. Biochemistry 33, 5974–5983 (1994). [DOI] [PubMed] [Google Scholar]
- Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem 254, 9627–9632 (1979). [PubMed] [Google Scholar]
- Kiefhaber T. Kinetic traps in lysozyme folding. Proceedings of the National Academy of Sciences of the United States of America 92, 9029–9033 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmid F. X. Mechanism of folding of ribonuclease A. Slow refolding is a sequential reaction via structural intermediates. Biochemistry 22, 4690–4696 (1983). [DOI] [PubMed] [Google Scholar]
- Schmid F. X. Fast-folding and slow-folding forms of unfolded proteins. Methods Enzymol 131, 70–82 (1986). [DOI] [PubMed] [Google Scholar]
- Onuchic J. N., Luthey-Schulten Z. & Wolynes P. G. Theory of protein folding: the energy landscape perspective. Annual review of physical chemistry 48, 545–600, 10.1146/annurev.physchem.48.1.545 (1997). [DOI] [PubMed] [Google Scholar]
- Li W., Wang W. & Takada S. Energy landscape views for interplays among folding, binding, and allostery of calmodulin domains. Proceedings of the National Academy of Sciences of the United States of America 111, 10550–10555, 10.1073/pnas.1402768111 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bachmann A. & Kiefhaber T. Apparent two-state tendamistat folding is a sequential process along a defined route. J Mol Biol 306, 375–386, 10.1006/jmbi.2000.4399 (2001). [DOI] [PubMed] [Google Scholar]
- Stoller G. et al. A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. EMBO J 14, 4939–4948 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Merz F. et al. Molecular mechanism and structure of Trigger Factor bound to the translating ribosome. EMBO J 27, 1622–1632, 10.1038/emboj.2008.89 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldstein R. A. The structure of protein evolution and the evolution of protein structure. Current opinion in structural biology 18, 170–177, 10.1016/j.sbi.2008.01.006 (2008). [DOI] [PubMed] [Google Scholar]
- Taverna D. M. & Goldstein R. A. Why are proteins so robust to site mutations? J Mol Biol 315, 479–484, 10.1006/jmbi.2001.5226 (2002). [DOI] [PubMed] [Google Scholar]
- Ingles-Prieto A. et al. Conservation of protein structure over four billion years. Structure 21, 1690–1697, 10.1016/j.str.2013.06.020 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fischer G. Chemical aspects of peptide bond isomerisation. Chemical Society Reviews 29, 119–127, 10.1039/A803742f (2000). [DOI] [Google Scholar]
- Kiefhaber T., Grunert H. P., Hahn U. & Schmid F. X. Replacement of a cis proline simplifies the mechanism of ribonuclease T1 folding. Biochemistry 29, 6475–6480 (1990). [DOI] [PubMed] [Google Scholar]
- Crespo M. D. et al. Quality control of disulfide bond formation in pilus subunits by the chaperone FimC. Nat Chem Biol 8, 707–713, 10.1038/nchembio.1019 (2012). [DOI] [PubMed] [Google Scholar]
- Mossner E., Huber-Wunderlich M. & Glockshuber R. Characterization of Escherichia coli thioredoxin variants mimicking the active-sites of other thiol/disulfide oxidoreductases. Protein Sci 7, 1233–1244, 10.1002/pro.5560070519 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellman G. L. Tissue sulfhydryl groups. Arch Biochem Biophys 82, 70–77 (1959). [DOI] [PubMed] [Google Scholar]
- Gill S. C. & von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182, 319–326 (1989). [DOI] [PubMed] [Google Scholar]
- Mossner E. et al. Importance of redox potential for the in vivo function of the cytoplasmic disulfide reductant thioredoxin from Escherichia coli. J Biol Chem 274, 25254–25259 (1999). [DOI] [PubMed] [Google Scholar]
- Kabsch W. Xds. Acta Crystallogr D Biol Crystallogr 66, 125–132, 10.1107/S0907444909047337 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winn M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235–242, 10.1107/S0907444910045749 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCoy A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658–674, 10.1107/S0021889807021206 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adams P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94–106, 10.1016/j.ymeth.2011.07.005 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66, 12–21, 10.1107/S0907444909042073 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson S. E. & Fersht A. R. Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition. Biochemistry 30, 10428–10435 (1991). [DOI] [PubMed] [Google Scholar]
- Brandts J. F., Halvorson H. R. & Brennan M. Consideration of the Possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry 14, 4953–4963 (1975). [DOI] [PubMed] [Google Scholar]
- Loferer H., Wunderlich M., Hennecke H. & Glockshuber R. A bacterial thioredoxin-like protein that is exposed to the periplasm has redox properties comparable with those of cytoplasmic thioredoxins. J Biol Chem 270, 26178–26183 (1995). [DOI] [PubMed] [Google Scholar]
- Rost J. & Rapoport S. Reduction-Potential of Glutathione. Nature 201, 185 (1964). [DOI] [PubMed] [Google Scholar]
- Bachmann A. K., T. in Protein Folding Handbook, Part 1 Vol. 1 (ed J; Kiefhaber Buchner T. ) Ch. 12.1, 379–410 (WILEY-VCH, 2005). [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.